Literature DB >> 7583919

Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates.

M P Nair1, K C Chadha, I Stadler, A Sweet, S A Schwartz.   

Abstract

While considerable progress in examining the course of human immunodeficiency virus (HIV) infection in adults has been made, a better understanding of the natural history of perinatal HIV infection remains to be obtained. Dysregulation of the production and functions of various cytokines, especially the interferons (IFNs), during HIV infections has been reported. Using an in vitro model system, we examined the effects of the HIV type 1 envelope protein, gp120 (10, 50, and 100 ng/ml), on gamma IFN (IFN-gamma) and IFN-alpha production by lymphocytes from neonates and adults and also examined the potential regulatory effects of gp120 on phorbol 12-myristate acetate (PMA)- and Sendai virus-induced IFN-gamma and IFN-alpha production by lymphocytes. PMA at a concentration of 50 ng/ml plus 50 ng of calcium ionophore A23187 per ml was used to induce IFN-gamma, while 150 hemagglutinating units of Sendai virus was used to induce IFN-alpha production. The antiviral activity of both IFN-alpha and IFN-gamma in leukocyte culture supernatants was assayed on BG-9 cells by a dye uptake technique using vesicular stomatitis virus as a challenge virus. Placental cord blood leukocyte (CBL) samples from healthy, term infants and adult peripheral blood leukocytes (APBL) produced no IFN in response to gp120. However, CBL produced significantly decreased levels of IFN-gamma compared with APBL in response to PMA plus ionophore. gp120 significantly suppressed both Sendai virus-induced IFN-alpha and PMA-induced IFN-gamma production by both CBL and APBL in a dose-dependent manner. However, gp120-induced suppression of IFN-alpha and IFN-gamma was significantly greater with CBL than with APBL. Treatment of CBL and APBL with gp120 did not induce any phenotypic alteration of the CD45 RO+ subset. Increased suppression of IFN-alpha and IFN-gamma production by gp120 in neonates may partially explain their apparent increased susceptibility to the clinical progression of HIV infections compared with that of adults.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583919      PMCID: PMC170174          DOI: 10.1128/cdli.2.4.434-438.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  42 in total

1.  Interferon inhibitors.

Authors:  J L Ambrus; K C Chadha; J L Ambrus
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

2.  Macrophage-derived cytokines in the cerebrospinal fluid of HIV-1-infected patients.

Authors:  P Gallo; A M Laverda; A De Rossi; S Pagni; P Cogo; V Argentiero; E Francavilla; M G Piccinno; A del Mistro; P Cadrobbi
Journal:  Acta Neurol (Napoli)       Date:  1990-02

3.  Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes.

Authors:  M P Nair; S A Schwartz
Journal:  Brain Behav Immun       Date:  1995-03       Impact factor: 7.217

Review 4.  HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease.

Authors:  J E Merrill; I S Chen
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

Review 5.  The role of interferon and tumor necrosis factor in the pathogenesis of AIDS.

Authors:  A S Lau; B R Williams
Journal:  J Exp Pathol       Date:  1990

6.  The interferon system in carcinoma of the cervix. Effect of radiation and chemotherapy.

Authors:  K C Chadha; J L Ambrus; J Halpern; M Khalil; S Sayyid; M S Piver; M M Hreshchyshyn
Journal:  Cancer       Date:  1991-01-01       Impact factor: 6.860

7.  Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2.

Authors:  S K Tyring; R Cauda; M Tumbarello; L Ortona; R C Kennedy; T C Chanh; P Kanda
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

8.  Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells.

Authors:  D B Lewis; C C Yu; J Meyer; B K English; S J Kahn; C B Wilson
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 9.  Defective signal transduction--a common pathway for cellular dysfunction in HIV infection?

Authors:  A J Pinching; K E Nye
Journal:  Immunol Today       Date:  1990-07

10.  A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.

Authors:  H E Gendelman; R M Friedman; S Joe; L M Baca; J A Turpin; G Dveksler; M S Meltzer; C Dieffenbach
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  1 in total

1.  Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2.

Authors:  M P Nair; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2000-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.